RT Journal Article
SR Electronic
T1 Mortality and risk factors among US Black, Hispanic, and White patients with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.08.20190686
DO 10.1101/2020.09.08.20190686
A1 Tomi Jun
A1 Sharon Nirenberg
A1 Patricia Kovatch
A1 Kuan-lin Huang
YR 2020
UL http://medrxiv.org/content/early/2020/09/11/2020.09.08.20190686.abstract
AB Background Little is known about risk factors for COVID-19 outcomes, particularly across diverse racial and ethnic populations in the United States.Methods In this prospective cohort study, we followed 3,086 COVID-19 patients hospitalized on or before April 13, 2020 within an academic health system in New York (The Mount Sinai Health System) until June 2, 2020. Multivariable logistic regression was used to evaluate demographic, clinical, and laboratory factors as independent predictors of in-hospital mortality. The analysis was stratified by self-reported race and ethnicity.Findings A total of 3,086 COVID-19 patients were hospitalized, of whom 680 were excluded (78 due to missing race or ethnicity data, 144 were Asian, and 458 were of other unspecified race/ethnicity). Of the 2,406 patients included, 892 (37.1%) were Hispanic, 825 (34.3%) were black, and 689 (28.6%) were white. Black and Hispanic patients were younger than White patients (median age 67 and 63 vs. 73, p<0.001 for both), and they had different comorbidity profiles. Older age and baseline hypoxia were associated with increased mortality across all races. There were suggestive but non-significant interactions between Black race and diabetes (p=0.09), and obesity (p=0.10). Among inflammatory markers associated with COVID-19 mortality, there was a significant interaction between Black race and interleukin-1-beta (p=0.04), and a suggestive interactions between Hispanic ethnicity and procalcitonin (p=0.07) and interleukin-8 (p=0.09).Interpretation In this large, racially and ethnically diverse cohort of COVID-19 patients in New York City, we identified similarities and important differences across racial and ethnic groups in risk factors for in-hospital mortality.Funding Icahn School of Medicine at Mount Sinai, New York, NY.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding: Icahn School of Medicine at Mount Sinai, New York, NY.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study utilized de-identified data extracted from the electronic health record and as such was considered non-human subject research. Therefore, this study was granted an exemption from the Mount Sinai IRB review and approval process.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPlease contact the authors for data requests.